Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Emerging treatment approaches for triple-negative breast cancer.
Capuozzo M, Celotto V, Santorsola M, Fabozzi A, Landi L, Ferrara F, Borzacchiello A, Granata V, Sabbatino F, Savarese G, Cascella M, Perri F, Ottaiano A. Capuozzo M, et al. Among authors: perri f. Med Oncol. 2023 Dec 1;41(1):5. doi: 10.1007/s12032-023-02257-6. Med Oncol. 2023. PMID: 38038783 Review.
Ipilimumab in the treatment of metastatic melanoma: management of adverse events.
Della Vittoria Scarpati G, Fusciello C, Perri F, Sabbatino F, Ferrone S, Carlomagno C, Pepe S. Della Vittoria Scarpati G, et al. Among authors: perri f. Onco Targets Ther. 2014 Feb 19;7:203-9. doi: 10.2147/OTT.S57335. eCollection 2014. Onco Targets Ther. 2014. PMID: 24570590 Free PMC article. Review.
Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives.
Marra A, Ferrone CR, Fusciello C, Scognamiglio G, Ferrone S, Pepe S, Perri F, Sabbatino F. Marra A, et al. Among authors: perri f. Anticancer Agents Med Chem. 2018;18(2):166-181. doi: 10.2174/1871520618666171219115335. Anticancer Agents Med Chem. 2018. PMID: 29256359 Review.
Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer.
Ottaiano A, Circelli L, Lombardi A, Scala S, Martucci N, Galon J, Buonanno M, Scognamiglio G, Botti G, Hermitte F, Savarese G, D'Amore L, Tatangelo F, Di Mauro A, Liguori G, Trotta AM, Napolitano M, Capozzi M, Tafuto S, Perri F, La Rocca A, Caraglia M, Nasti G. Ottaiano A, et al. Among authors: perri f. Cell Death Dis. 2020 Apr 24;11(4):275. doi: 10.1038/s41419-020-2480-6. Cell Death Dis. 2020. PMID: 32332709 Free PMC article.
Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer.
Ottaiano A, Caraglia M, Di Mauro A, Botti G, Lombardi A, Galon J, Luce A, D'Amore L, Perri F, Santorsola M, Hermitte F, Savarese G, Tatangelo F, Granata V, Izzo F, Belli A, Scala S, Delrio P, Circelli L, Nasti G. Ottaiano A, et al. Among authors: perri f. Cancers (Basel). 2020 Oct 21;12(10):3073. doi: 10.3390/cancers12103073. Cancers (Basel). 2020. PMID: 33096795 Free PMC article.
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol.
Ottaiano A, Scala S, Santorsola M, Trotta AM, D'Alterio C, Portella L, Clemente O, Nappi A, Zanaletti N, De Stefano A, Avallone A, Granata V, Notariello C, Luce A, Lombardi A, Picone C, Petrillo A, Perri F, Tatangelo F, Di Mauro A, Albino V, Izzo F, Rega D, Pace U, Di Marzo M, Chiodini P, De Feo G, Del Prete P, Botti G, Delrio P, Caraglia M, Nasti G. Ottaiano A, et al. Among authors: perri f. Ther Adv Med Oncol. 2021 Mar 24;13:1758835921989223. doi: 10.1177/1758835921989223. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33854566 Free PMC article.
330 results